Ipasa

Ipasa, established in 2013, is a pivotal voluntary association in South Africa dedicated to enhancing lives through accelerated access to innovative pharmaceutical treatments. Representing 22 leading research-based pharmaceutical companies, Ipasa champions a sustainable environment conducive to pharmaceutical research and development. The organization actively addresses critical healthcare challenges by fostering robust collaboration between public and private sectors across the continent. Its strategic focus is on pioneering new therapies and ensuring their effective delivery to patients.

Operating with a team of 500 - 1,000 employees, Ipasa generates an annual revenue of $42.2M. The association's core activities revolve around promoting cutting-edge research and development, ensuring that breakthrough medical advancements are accessible. Through strategic partnerships and a commitment to operational excellence, Ipasa facilitates the seamless integration of novel treatments into the healthcare landscape. Meet Ipasa's team to understand the leadership driving these initiatives and their dedication to advancing medical science and patient care within South Africa.

Ipasa's commitment extends beyond research to significant investments in community health initiatives and the continuous training of healthcare professionals. This comprehensive approach aims to bolster the overall health system and significantly improve patient outcomes nationwide. By advocating for policies that support innovation and patient access, Ipasa plays a crucial role in shaping a healthier future for South Africa, ensuring that vital medications and diagnostic tools reach those who need them most.